Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cell Source, Inc. (CLCS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2022 |
8-K
| Quarterly results |
| 05/06/2022 |
8-K
| Quarterly results |
| 03/11/2022 |
8-K
| Quarterly results |
| 04/01/2021 |
8-K
| Quarterly results |
| 04/19/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/16/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/05/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/19/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Cell Source Appoints Dr. Dennis Brown as Chairman of its Board of Directors New York, NY, August 19th, 2015 -- Cell Source, Inc. a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Dennis Brown, currently a Director of Cell Source, has been appointed Chairman of the Board of Directors. Itamar Shimrat, CEO of Cell Source stated “Dr. Brown’s proven track record of developing and commercializing pharmaceutical products and his past experience as an inventor, executive and chairman of biopharmaceutical companies positions him well to lead Cell Source as it makes significant strides towards commercializing its technology. Dr. Brown, who joined our Board last year, has become both a thought leader and ac..." |
|
| 07/28/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 06/10/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 06/03/2015 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 05/28/2015 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 04/01/2015 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 12/02/2014 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
| 07/01/2014 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...|
Docs:
|
"Share Exchange Agreement, by and between Cell Source, Ltd., and Ticket to See, Inc",
"Articles of Association of Cell Source Limited, as amended on November 11, 2013",
"Form of Subscription Agreement",
"Form of Registration Rights Agreement",
"Form of Investor Warrant",
"Form of Researcher Company Warrant",
"Form of Company Warrant",
"Research and License Agreement by and between Yeda Research and Development Company Limited and Cell Source Limited",
"Amendment to Research and License Agreement",
"Amendment to Evaluation and Exclusive Option Agreement by and between Yeda Research and Development Company Limited and Cell Source Limited" |
|
| 06/30/2014 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 06/26/2014 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 06/06/2014 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
|
|